← Leaderboards
Gregory John Dore
University Of New South Wales
$1,774,464
Attributed
$1,774,464
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $364K · FY2010–14$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,774,464 · 1
By mechanism
R01$1,774,464 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acute Hepatitis”
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$146,357,255
- Judith S. Currier · University Of California Los Angeles$138,197,986
- T John Winhusen · University Of Cincinnati$32,733,788
- Russell E Ware · Duke University$32,247,614
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Rebecca D Jackson · Ohio State University$29,698,788
Research focus
Acute HepatitisAcuteAdherence (Attribute)AffectAntiviral TherapyAcute Hepatitis CBaseChronic Hepatitis CClinical Trials DesignCombined Modality TherapyDesignDetectionDeveloped CountriesAreaEarly DiagnosisEffective TherapyEnrollmentEvaluationFutureGenesGenomeGenotypeGlobal HealthGrant
Grant awards (5)
Treatment of recently acquired hepatitis C virus infection$360,384
R01 · FY2014 · DA · contact PI
Treatment of recently acquired hepatitis C virus infection$341,380
R01 · FY2013 · DA · contact PI
Treatment of recently acquired hepatitis C virus infection$363,999
R01 · FY2012 · DA · contact PI
Treatment of recently acquired hepatitis C virus infection$355,137
R01 · FY2011 · DA · contact PI
Treatment of recently acquired hepatitis C virus infection$353,564
R01 · FY2010 · DA · contact PI